A study from the La Trobe University on the impact of deregulation of the abortion pills, MS-2 Step, revealed that the number of chemists stocking the drugs has almost doubled.
by Kathy Clubb
What is MS-2 Step?
MS-2 Step, also known as the abortion pill, is produced by Marie Stopes International and was formerly known as RU-486. The change of name reflects the two-stage protocol for inducing an abortion via chemicals. First the drug Mifepristone is consumed to stop progesterone production, effectively stopping a baby from accessing nutrition from its mother. Then thirty-six to forty-eight hours later, the drug Misoprostol is taken to expel the child. At that point, the baby is expected to have died, but that is not always the case. Many mothers have traumatically delivered live babies into their toilets at home, this is more likely when the mother takes the drugs later in her pregnancy.
MS-2 Step is available in Australia under the Pharmaceutical Benefits Scheme and is recommended for use until sixty-three days gestation.
Effects of deregulation
After the Therapeutic Goods Administration made changes in 2023, the number of pharmacies selling MS-2 Step increased from 2,228 to 4,107. This increase reflects the TGA’s decision to eliminate the need for pharmacists to be registered before they could dispense chemical abortion drugs.
The new figures, reported by La Trobe University’s School of Nursing and Midwifery, show that mothers have access to the abortion pill in almost half of the postcodes around Australia – this has long been a goal of abortion advocates, who frequently describe a “postcode lottery” when referring to what is, in their view, limited abortion access.
Along with that change for pharmacists, GP’s were no longer required to be registered or to have specialised training before prescribing the drugs. Additionally, midwives and nurse practitioners were given permission to prescribe them.
A new brand of abortion drug on the market
Until recently, MS-2 Step was the only abortion pill available in Australia, with that product being the sole focus of the La Trobe University study. However, a second chemical abortion drug was released this month, having been approved by the TGA in February.
The drug, Arzestra, comprising the same two medicines, is registered as a “generic drug”, making it a lower-cost alternative to MS-2 Step. There is little information available about Arzestra – it is not yet possible even to view the packaging. But there is little doubt that once it hits the shelves, there will be an even greater rise in the number of abortions using chemicals.
Rebellion at the heart of abortion
With abortion pills so readily available and increasingly becoming the preferred method for killing unborn babies worldwide, it is no wonder that we are witnessing the blatant promotion of their use by abortion activists.
Two examples of this spring readily to mind. In Poland, activists have just begun providing abortion pills via lockers placed strategically near the Warsaw Parliament building. The locker system is known by the chilling term “abortomat” in Polish. Mother can use a six-digit code to open one of the doors and access abortion pills in hostile opposition to the nation’s stringent anti-abortion laws.
In the US, the Satanic Temple recently released the horrifying music video about a woman consuming an abortion pill as part of an “abortion ritual.” The video was filmed inside the toilet of a Hobby Lobby store, to highlight that company’s opposition to abortion.
How is this healthcare?
According to this report, abortion advocates are, perhaps unsurprisingly, still not content with the availability of abortion around Australia. Dr Anna Noonan, an abortion researcher with the University of Technology Sydney, said that despite the increase in accessibility reported by La Trobe University, more expansion is necessary.
Dr. Noonan said her research showed that medical professionals are already facilitating that expansion. She claims:
Doctors and nurses are going to pharmacies in advance saying, ‘I’m going to be an abortion provider in this community, will you stock this medication?’
She also suggests that regulation “harms” patients, especially those on limited means:
“The more we encourage a deregulated environment, the easier access will be, particularly for people with less resources.”
“People with less resources” is code for those on the lower socio-economic rungs. It should come as no surprise to see a promoter of abortion trying to ensure that there are fewer children being born to poor families.
De-regulation is not progress
There needs to be a halt to the use of drugs for abortions, rather than an expansion. Their danger to babies is obvious, the harms to mothers are well-documented.
Experience overseas shows that apart from killing babies and potentially harming mothers, the ease with which the chemical abortion regimen can be obtained leads to serious abuses. It is becoming alarmingly common to hear of mothers being slipped abortion pills by their partners or family members, in order to surreptitiously kill their unborn babies. ( See here, here and here.)
There is no other form of “healthcare” that allows someone to so easily force death upon a child or an unsuspecting mother. Allowing for greater access to abortion pills is not a sign of progress, but of barbarism, of a society in decline.











